US approves world's costliest drug to treat rare childhood disorder

Zolgensma was a one-time treatment for spinal muscular atrophy, a disease that affects about 1 in 10,000 births and which results in death or the need for permanent ventilation by the age of two in 90 percent of cases.

from Hindustan Times - world http://bit.ly/2K4MJVM
https://ift.tt/2zbki14